ESG Report 2025

Summary of “The United Laboratories Fair Pricing Policy” Fair Pricing Principles 1.Principle of Legal Compliance: Comply with relevant laws, regulations and other regulatory requirements, strictly follow internal and external approval procedures, and shall not harm the public interest or the legitimate rights and interests of relevant individuals. 2.Principle of Fairness: Based on the concept of product affordability, set product prices fairly both domestically and internationally. 3.Principle of Accessibility: As a special commodity, the accessibility of medicines relates to health and human rights. The Group pays attention to health equity among different countries and regions and is committed to providing safe and effective medicines. 4.Principle of Sustainable Innovation: The value-based product pricing strategy is the foundation of the Group's pricing model. The pricing mechanism should support and incentivise the Group's continuous investment in product innovation and R&D. Fair Pricing Measures 1.Adopt a value-based product pricing strategy to ensure that drug pricing reflects its value to patients, healthcare systems and the broader local society. 2.For different product types, adopt scientific, reasonable and differentiated pricing strategies that are consistent with the above fair pricing principles. 3.Based on the concept of product affordability, set product prices fairly both domestically and internationally. The Group adopts a differentiated pricing mechanism based on national and regional development levels. That is, when pricing products in different countries or in different regions within the same country, factors such as the GDP level, the United Nations Human Development Index, and public healthcare expenditure of the relevant country/region shall be taken into account to ensure that product prices are relatively consistent across countries/regions at the same development level and across markets of the same level within the same country. Develop more accessible product pricing strategies according to the needs and affordability of patients in different countries/regions, serving more patients worldwide. 4.Periodically review the current product pricing system and make reasonable adjustments based on market changes, cost fluctuations, policy impacts and other factors. Review and Supervision The Group's relevant departments – including medical, marketing, finance and legal – evaluate and review product pricing to ensure the effectiveness of this policy. The Group's Board of Directors supervises the implementation of the Fair Pricing Policy. Employee Training The Group provides relevant training on this policy to all employees each year. All Group employees shall participate in such training, understand, master and comply with all provisions of this policy. 61 Based on the above principles, the Group implements reasonable pricing and partial profit-sharing. In some African countries, the average price of core anti-infective APIs is approximately 10%-20% lower than in developed markets. In addition, the Group provides humanitarian profit-sharing support to developing countries affected by natural disasters or wars, assisting in local post-disaster reconstruction and public health emergency response. The United Laboratories International Holdings Limited 2025 Environmental, Social and Governance Report